Clinical Casebook: Real-World Animal Disease Investigations and Treatments

• Introduction
• Chapter 1 Acute Toxoplasma gondii Infection in a Dog
• Chapter 2 Skin Infection Caused by Bacteria and a Novel Fungal Pathogen (Trichocladium sp.) in a Dog
• Chapter 3 Immune-Mediated Hemolytic Anemia (IMHA) in a Puppy
• Chapter 4 Chronic Pyelonephritis in a Dog
• Chapter 5 "Triaditis" in a Cat
• Chapter 6 Feline Infectious Peritonitis (FIP) Suspected in a Cat
• Chapter 7 Atypical Mycobacteriosis in a Cat
• Chapter 8 Chordoma in a Ferret
• Chapter 9 "Hardware Disease" in Backyard Chickens
• Chapter 10 Coccidioidomycosis in a Llama
• Chapter 11 Budd-Chiari-Like Syndrome in a Domestic Rabbit
• Chapter 12 Pituitary-Dependent Hyperadrenocorticism and Cholangiohepatitis in a Guinea Pig
• Chapter 13 Endometrial Venous Aneurysm in a Lionhead Rabbit
• Chapter 14 Anorexia and Lethargy in an 8-Month-Old Chameleon
• Chapter 15 Iguana with Mast Cell Tumors
• Chapter 16 Bloat in Ruminants
• Chapter 17 Pinkeye (Infectious Keratoconjunctivitis) in Cattle
• Chapter 18 Bacillary Hemoglobinuria in Feeder Cattle
• Chapter 19 Arsenic Toxicosis in Calves
• Chapter 20 Mastitis in Dairy Cattle
• Chapter 21 Contagious Footrot in Sheep
• Chapter 22 Abortion of a Sheep Fetus Due to Cache Valley Fever Virus
• Chapter 23 Reducing Escherichia coli Infections in Neonatal Lambs: A Farm Case Study
• Chapter 24 Asthma in Horses
• Chapter 25 Severe Case of Life-Threatening Pneumonia in a Horse

Veterinary medicine stands at the intersection of science, compassion, and complex problem-solving. Every day, veterinarians face an ever-changing landscape of clinical cases in diverse animal species—each presenting with its own unique diagnostic challenges, therapeutic decisions, and ethical dilemmas. The art and science of clinical reasoning form the cornerstone of effective veterinary practice, guiding the practitioner from an animal's presenting concern through history-taking, the formulation of a differential diagnosis, strategic diagnostic testing, and, ultimately, to a tailored management plan.

This book, Clinical Casebook: Real-World Animal Disease Investigations and Treatments, offers an extensive and nuanced exploration of veterinary diagnostic and clinical reasoning through the lens of actual case studies. Drawing from both clinic and farm settings, each chapter meticulously walks through the progression of real cases—detailing the critical decisions, investigative steps, and treatment options considered along the way. By using cases from companion animals, exotics, and farm animals alike, this collection demonstrates the wide-ranging skills required of veterinary professionals, as well as the adaptability necessary to confront new and unexpected clinical problems.

Central to each case are the processes of problem representation, evidence-based differential diagnosis, and client communication. The importance of thorough history-taking and physical examination is emphasized, but so too is the vital role of diagnostic laboratories and advanced imaging—especially in the identification and management of complex, emerging, or rare diseases. Whether the case involves a common infectious disease in a cat, an obscure toxic exposure in a herd of cattle, or an innovative surgical intervention in an exotic species, the lessons learned are universally applicable to the broader veterinary community.

Yet, this casebook is not merely a catalogue of successful outcomes. It highlights clinical setbacks and complications, recognizing that they too are invaluable for deepening professional understanding and improving practice. Readers are encouraged to critically analyze the successes and failures within each narrative, reflecting on the nuances of judgment, the limitations of diagnostics or therapies, and the unpredictable nature of clinical medicine. In this way, the book becomes not just a compilation of instructive stories, but also a dynamic guide to practical problem-solving and continuous learning.

The veterinary field continues to evolve rapidly, shaped by advancements in diagnostics, growing antimicrobial resistance, shifting epidemiological patterns, and a heightened recognition of the One Health relationship between animals, humans, and the environment. This book is mindful of these emerging trends and challenges, offering not only a window into current best practices but also prompting readers to consider how veterinary medicine must continually adapt to meet the health needs of animals and society alike.

Whether you are a student seeking to sharpen your diagnostic skills, a practicing veterinarian looking for practical insights, or an educator searching for real-world teaching material, Clinical Casebook: Real-World Animal Disease Investigations and Treatments aims to serve as a resource and inspiration. Through detailed, real-world stories and thoughtful analysis, it invites readers to embrace the complexity of animal health and carry forward the principles of careful reasoning and compassionate care into their own practices.

The waiting room at the clinic buzzed with the usual symphony of anxious barks and the occasional cat's disgruntled yowl. But the case of Max, a mixed-breed adult dog, brought a different kind of tension. Max's owner, a kind woman named Sarah, described a rapid decline in his health: progressive lethargy, a fever that seemed to spike intermittently, and a noticeable, uncomfortable abdominal distension. Max had always been a resilient dog, a former stray with a spirit as robust as his mixed heritage. However, his recent history complicated matters significantly. Just a few weeks prior, he had been diagnosed with immune-mediated hemolytic anemia (IMHA), a serious condition where his own immune system was mistakenly destroying his red blood cells. To combat this, Max had been prescribed prednisone and another immunosuppressant medication, a necessary but double-edged sword that left him vulnerable to opportunistic infections.

When Max arrived, he was visibly weak, his eyes sunken, and his normally wagging tail lay limp. His abdomen was indeed distended and taut to the touch, suggesting a significant accumulation of fluid. Dr. Evelyn Reed, the attending veterinarian, began her examination with a thorough physical assessment. She noted Max's elevated temperature, his shallow and rapid breathing, and the overall impression of a dog struggling against an unseen assailant. His mucous membranes were pale, a lingering sign of his IMHA, but the other symptoms pointed to something new and acutely concerning.

The immediate priority was to investigate the cause of the abdominal distension and Max's systemic illness. Dr. Reed performed an abdominocentesis, carefully drawing a sample of the accumulated fluid from his belly. The fluid was somewhat turbid, not a clear, benign effusion. Under the microscope, a quick cytology revealed the presence of numerous protozoal organisms. This was a critical piece of the puzzle, immediately narrowing the differential diagnosis to parasitic infections.

Given Max's immunocompromised state due to his IMHA treatment, the presence of protozoa raised a significant red flag for opportunistic infections. Toxoplasma gondii immediately jumped to the top of Dr. Reed's list of suspects. Toxoplasma gondii is a common intracellular protozoan parasite that can infect all warm-blooded animals, including dogs and humans. While healthy adult dogs often remain asymptomatic, puppies and immunocompromised dogs can develop severe, multi-systemic disease. The parasite’s lifecycle involves cats as definitive hosts, shedding oocysts in their feces, while other animals, including dogs, act as intermediate hosts. Infection in dogs typically occurs through ingesting contaminated cat feces, soil, water, or, more commonly, by eating raw or undercooked meat containing tissue cysts.

The decision was made to send the abdominal fluid for specific Toxoplasma gondii testing using real-time Polymerase Chain Reaction (rtPCR). PCR is a molecular diagnostic technique known for its high sensitivity and specificity in detecting parasitic DNA. While awaiting the rtPCR results, Dr. Reed also ordered additional serological tests: Toxoplasma gondii IgG and IgM antibody panels, and a Neospora caninum IFA on serum. Neospora caninum is another protozoan parasite that causes neurological disease in dogs and can present with similar clinical signs, making it an important differential to rule out.

The rtPCR result came back positive for Toxoplasma gondii with a low Ct value, indicating a significant parasitic load in the abdominal fluid. This confirmed the acute Toxoplasma gondii infection. The serological results further supported this diagnosis: high levels of IgG antibodies were detected, indicating prior exposure, but importantly, IgM antibodies were not detected. While high IgM levels typically suggest an active, recent infection, it's not always exclusively present in acute cases, especially in immunocompromised animals where the immune response might be atypical. The absence of Neospora caninum antibodies effectively ruled out that particular differential.

The diagnosis of acute Toxoplasma gondii infection in an immunocompromised dog like Max was grave. The prognosis for dogs with hepatic, central nervous system (CNS), or pulmonary disease due to toxoplasmosis, particularly those already immunocompromised, is often poor. However, early and aggressive treatment can improve outcomes, especially in preventing further progression of neurological signs if present. The immediate goal was to suppress the active multiplication of the parasite and support Max’s organ systems.

Dr. Reed initiated treatment with clindamycin, which is often considered the drug of choice for clinical toxoplasmosis in dogs and cats. It is typically administered orally at a dose of 10-12.5 mg/kg every 8 to 12 hours. In severe or systemic cases, a combination therapy with sulfonamides (like sulfadiazine) and pyrimethamine or trimethoprim-sulfa might also be considered, as pyrimethamine is thought to be more effective than trimethoprim against T. gondii. These drugs aim to suppress parasite replication rather than completely eliminating the infection, meaning a relapse is always possible, especially with continued immunosuppression.

Max also received supportive care, which included intravenous fluids to combat dehydration and maintain electrolyte balance, given his lethargy and poor appetite. Pain management was addressed as needed, though the primary focus remained on tackling the parasitic infection. Nutritional support was also crucial, to help his weakened body fight the infection. Since Max was already on immunosuppressive medication for IMHA, a delicate balance had to be struck. The prednisone dose, and the other immunosuppressant, would need to be carefully re-evaluated and potentially adjusted as his condition progressed, to avoid further compromising his immune system while still managing his IMHA.

Over the next few days, Max's progress was closely monitored. The initial signs of clinical improvement, such as a reduction in fever and increased activity, are typically expected within a week of starting treatment. However, treatment for toxoplasmosis generally needs to continue for at least four weeks, and sometimes up to six weeks, to ensure the best possible outcome. Frequent re-evaluations, including repeat blood work and potentially abdominal fluid analysis, would be necessary to assess the effectiveness of the therapy and to watch for any adverse drug reactions.

While Max's immediate crisis began to stabilize, his case underscored several critical lessons. Firstly, the importance of considering opportunistic infections in any immunocompromised patient cannot be overstated. When the body's natural defenses are weakened, otherwise benign or subclinical infections can rapidly become life-threatening. Secondly, the power of advanced diagnostic tools, such as rtPCR, in confirming a diagnosis quickly and accurately is invaluable, especially when clinical signs can be vague or mimic other conditions. Serology, while helpful for indicating exposure, needs to be interpreted carefully in conjunction with clinical signs and other diagnostics to confirm an active infection.

Finally, Max's recovery would be a testament to the collaborative effort between his owner and the veterinary team. Sarah's diligent observation and prompt action were vital in bringing Max to the clinic when he did. Her commitment to his ongoing care, including administering medications and monitoring his well-being at home, would be instrumental in his long-term recovery. Even with successful treatment, dogs infected with T. gondii may remain seropositive for life, and a relapse remains a possibility during future periods of immunosuppression. Therefore, ongoing communication between Sarah and Dr. Reed would be essential to manage Max’s chronic health conditions and to prevent future flare-ups of toxoplasmosis.